Quest Diagnostics (DGX) Tops Q4 EPS by 2c, Offers Guidance
Tweet
Share
E-mail
Get Alerts DGX Hot Sheet
Price: $237.14 -0.94%
EPS Growth %: +10.0%
Financial Fact:
Net income: 205M
Today's EPS Names:
VIVO, BIOX, PMCB, More
EPS Growth %: +10.0%
Financial Fact:
Net income: 205M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Quest Diagnostics (NYSE: DGX) reported Q4 EPS of $1.40, $0.02 better than the analyst estimate of $1.38. Revenue for the quarter came in at $1.94 billion versus the consensus estimate of $1.94 billion.
GUIDANCE:
Quest Diagnostics sees FY2018 EPS of $6.50-$6.70, versus the consensus of $6.61.
For earnings history and earnings-related data on Quest Diagnostics (DGX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- EU proposes to curb Airbnb and short-term rentals amid housing shortage
- Dell’s earning report was bullish for Intel CPU demand, analyst says
- lululemon athletica (LULU) Tops Q2 EPS by $1.10, Cuts Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
